Every Form 4 that ChronoScale Holdings Corporation (CHRN) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow CHRN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CHRN filings page.
ChronoScale Holdings Corp (CHRN) reported that its Chief Financial Officer, Jerome Wong, received a grant of 300,000 restricted stock units (RSUs) on August 16, 2026. These RSUs convert into common shares on a one-for-one basis, have no expiration date, and vest one-third on May 5, 2027, with additional one-sixth installments every six months until full vesting on May 5, 2029, subject to continued service and potential accelerated vesting under certain conditions.
After this award, Wong holds 364,771 shares of common stock directly, which include 40,000 shares from vested performance-based RSUs and 24,771 shares from previously granted RSUs adjusted for a 1-for-15 reverse stock split, plus 4,184 shares indirectly via a 401(k) plan.
Jegannathan Rajasekar reported acquisition or exercise transactions in this Form 4 filing.
ChronoScale Holdings Corp Chief Technology Officer Jegannathan Rajasekar received a grant of 1,400,000 restricted stock units on July 22, 2026. The RSUs represent a contingent right to common shares and vest from June 1, 2027 through June 1, 2029, subject to continuous service, bringing his direct holdings to 1,402,587 shares.
Chen Ying Cenly reported acquisition or exercise transactions in this Form 4 filing.
ChronoScale Holdings Corp granted Chief Executive Officer Chen Ying Cenly 2,800,000 restricted stock units (RSUs) tied to its common stock on July 13, 2026. The RSUs have no expiration date and vest one-third on May 1, 2027, then in equal six-month installments until fully vested on May 1, 2029, subject to continuous service and possible accelerated vesting under certain conditions. Following the award, Cenly’s reported direct beneficial ownership is 2,800,000 shares.
Schaap Andrew Cordell reported acquisition or exercise transactions in this Form 4 filing.
ChronoScale Corp director Andrew Cordell Schaap received an equity grant of 200,000 shares of Common Stock as restricted stock. The grant was made on June 29, 2026 at a stated price of $0.00 per share and brings his reported direct holdings to 200,000 shares.
The award vests in two equal installments: 100,000 restricted shares vest on the one-year anniversary of the June 29, 2026 grant date and 100,000 restricted shares vest on the two-year anniversary. Vesting requires his continuous service with ChronoScale through each vesting date, with potential adjustment or accelerated vesting under certain conditions.
CLANCY WILLIAM M reported acquisition or exercise transactions in this Form 4 filing.
ChronoScale Corp director William M. Clancy received a grant of 200,000 restricted shares of common stock as equity compensation. The shares were awarded at no cash purchase price and are held directly.
According to the vesting schedule, 100,000 restricted shares will vest on the one-year anniversary of the May 14, 2026 grant date, and another 100,000 will vest on the two-year anniversary. Vesting requires his continuous service with the company through each vesting date, with potential adjustments or accelerated vesting under certain conditions. After this grant, Clancy owns 200,000 shares of ChronoScale common stock directly.
Cummins Wes reported acquisition or exercise transactions in this Form 4 filing.
ChronoScale Corp director Wes Cummins received a grant of 200,000 restricted shares of common stock as equity compensation. The grant was made on May 14, 2026 and all shares are held directly, bringing his reported direct common stock holdings to 200,000 shares.
According to the vesting schedule, 100,000 restricted shares will vest on the one-year anniversary of the grant date and the remaining 100,000 will vest on the two-year anniversary, conditioned on his continuous service with the company and subject to possible adjustment or accelerated vesting upon certain conditions.
Benson Ella G. reported acquisition or exercise transactions in this Form 4 filing.
ChronoScale Corp director Ella G. Benson received a grant of 200,000 shares of restricted common stock as compensation. The award was granted on May 14, 2026 at no cash purchase price and brings her direct holdings to 200,000 shares.
The grant vests in two equal tranches. 100,000 restricted shares vest on the one-year anniversary of the grant date, and the remaining 100,000 vest on the two-year anniversary. Vesting is conditioned on Benson’s continuous service with ChronoScale and may be adjusted or accelerated under certain conditions.
Nottenburg Richard N reported acquisition or exercise transactions in this Form 4 filing.
ChronoScale Corp reported that director Richard N. Nottenburg received a grant of 200,000 shares of restricted common stock on May 14, 2026. These shares were awarded at $0.00 per share as equity compensation, not as an open‑market purchase.
According to the vesting schedule, 100,000 restricted shares will vest on the first anniversary of the grant date and another 100,000 restricted shares will vest on the second anniversary. Vesting is conditioned on his continuous service with ChronoScale and may be adjusted or accelerated under certain conditions. After this grant, he directly holds 200,000 ChronoScale shares.
ChronoScale Corp Chief Financial Officer Jerome Wong reported new equity compensation and updated holdings. He received 40,000 shares of common stock at a price of $0.00 per share as a grant or award acquisition tied to performance-based restricted stock units under the company’s Amended and Restated 2014 Equity Incentive Plan. Following this award, he directly holds 64,771 shares of common stock and indirectly holds 4,184 shares through a 401(k) account.
MILLER DOUGLAS S reported acquisition or exercise transactions in this Form 4 filing.
ChronoScale Corp director Douglas S. Miller received a grant of 200,000 restricted shares of common stock as equity compensation. The award was granted on May 14, 2026 at no purchase price. According to the terms, 100,000 restricted shares vest on the one-year anniversary of the grant date and 100,000 vest on the two-year anniversary.
Each vesting tranche requires Miller to remain in continuous service with ChronoScale through the applicable vesting date, and the award may be adjusted or vest earlier under certain specified conditions. After this grant, Miller holds 200,000 shares directly.
ChronoScale Corp director Davis Scott G. reported a new stock award. He received 109,357 shares of common stock at no cost as a grant or award, increasing his direct holdings to 188,134 shares. The filing also notes 373 shares held indirectly through a 401(k) account.
The shares were acquired upon vesting of performance-based restricted stock units originally granted on November 5, 2025 under ChronoScale’s Amended and Restated 2014 Equity Incentive Plan and amended on May 14, 2026, highlighting that this is a compensation-related equity vesting rather than an open-market purchase or sale.